BACKGROUND: To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis. METHODS: Patients enrolled in the French ANRS SEROCO/HEMOCO cohort with CD4 count >500 cells/mm3 at HIV diagnosis. LTNP status was defined as being asymptomatic, antiretroviral free, and with CD4 cell count >500 cells/mm3 for >8 years after HIV diagnosis. In LTNPs, we modeled the biological markers' progression through a joint model. Factors associated with loss of LTNP status were identified through a Cox model. RESULTS: Sixty (9%) of 664 patients were identified as LTNPs during follow-up. At enrollment, HIV RNA was <or=2.6 log copies/mL in 24% of LTNPs and HIV DNA was <or=1.85 log copies/10 peripheral blood mononuclear cells (PBMCs) in 31% vs. 3% and 8% in others. In LTNPs, HIV RNA and HIV DNA levels increased by 0.04 log copies/mL per year and 0.07 log copies/10(6) PBMCs per year during the first 8 years after diagnosis. LTNP status was lost in 36 subjects; baseline HIV DNA >1.85 log copies/10(6) PBMCs and high HIV DNA increase were associated with an increased risk of losing LTNP status [adjusted hazard ratio: 2.8 (1.2-6.8) and 2.2 (1.0-4.8), respectively]. CONCLUSIONS: LTNP status is established in the first years of HIV infection, low HIV DNA level at enrollment and slow increase of HIV DNA being associated with maintained LTNP status.
BACKGROUND: To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis. METHODS:Patients enrolled in the French ANRS SEROCO/HEMOCO cohort with CD4 count >500 cells/mm3 at HIV diagnosis. LTNP status was defined as being asymptomatic, antiretroviral free, and with CD4 cell count >500 cells/mm3 for >8 years after HIV diagnosis. In LTNPs, we modeled the biological markers' progression through a joint model. Factors associated with loss of LTNP status were identified through a Cox model. RESULTS: Sixty (9%) of 664 patients were identified as LTNPs during follow-up. At enrollment, HIV RNA was <or=2.6 log copies/mL in 24% of LTNPs and HIV DNA was <or=1.85 log copies/10 peripheral blood mononuclear cells (PBMCs) in 31% vs. 3% and 8% in others. In LTNPs, HIV RNA and HIV DNA levels increased by 0.04 log copies/mL per year and 0.07 log copies/10(6) PBMCs per year during the first 8 years after diagnosis. LTNP status was lost in 36 subjects; baseline HIV DNA >1.85 log copies/10(6) PBMCs and high HIV DNA increase were associated with an increased risk of losing LTNP status [adjusted hazard ratio: 2.8 (1.2-6.8) and 2.2 (1.0-4.8), respectively]. CONCLUSIONS: LTNP status is established in the first years of HIV infection, low HIV DNA level at enrollment and slow increase of HIV DNA being associated with maintained LTNP status.
Authors: G Somi; M Majigo; J Manyahi; J Nondi; J Agricola; V Sambu; J Todd; A Rwebembera; N Makyao; A Ramadhani; Min Matee Journal: BMC Health Serv Res Date: 2017-08-07 Impact factor: 2.655
Authors: Sabine Kinloch-de Loes; Lucy Dorrell; Hongbing Yang; Gareth A D Hardy; Sabine Yerly; Cristina Cellerai; Linos Vandekerckhove; Ward De Spielgelaere; Eva Malatinkova; Willie Wee Lee Koh; Margaret A Johnson Journal: Open Forum Infect Dis Date: 2015-11-23 Impact factor: 3.835
Authors: Deepti Gurdasani; Louise Iles; David G Dillon; Elizabeth H Young; Ashley D Olson; Vivek Naranbhai; Sarah Fidler; Effrossyni Gkrania-Klotsas; Frank A Post; Paul Kellam; Kholoud Porter; Manjinder S Sandhu Journal: AIDS Date: 2014-01-14 Impact factor: 4.177